Chemerin influences endothelin- and serotonin-induced pulmonary artery vasoconstriction in rats

Life Sci. 2019 Aug 15:231:116580. doi: 10.1016/j.lfs.2019.116580. Epub 2019 Jun 16.

Abstract

Aims: Chemerin has been recently identified as a vasoactive adipokine implicated in blood pressure regulation. In this context, we evaluated whether chemerin could influence pulmonary vasoreactive response.

Materials and methods: Vascular reactivity to chemerin and to phenylephrine, serotonin and endothelin-1 after chemerin pretreatment was evaluated in rat isolated pulmonary artery versus thoracic aorta with and without endothelium. Vasoreactivity to acetylcholine in presence of nitric oxide (NO)-synthase inhibitor (L-NAME) and to NO donor sodium nitroprusside (SNP) was evaluated in chemerin-pretreated pulmonary artery versus thoracic aorta with endothelium. Pretreatment with ODQ, a soluble guanylate cyclase inhibitor and apocynin, a ROS production inhibitor, were also tested. Arteries and lung tissue were harvested for pathobiological evaluation.

Key findings: Chemerin contracted endothelium-denuded pulmonary artery, while no response was observed in arteries with endothelium. Chemerin potentiated phenylephrine-, endothelin-1- and serotonin-induced vasoconstriction, which was further enhanced by endothelium removal. Chemerin decreased acetylcholine-induced vasorelaxation in arteries with endothelium, while it did not affect SNP-induced relaxation. In presence of L-NAME, there remained a vasorelaxation in chemerin-pretreated arteries. Chemerin or ODQ alone partly decreased acetylcholine-induced vasorelaxation in pulmonary artery and thoracic aorta, while combined chemerin and ODQ incubation abolished it. Treatment with apocynin partly or totally reversed chemerin effects. In both types of arteries, chemerin reduced acetylcholine-induced NO production, as well as endothelial and inducible NO-synthase expression.

Significance: Chemerin potentiates vascular responses to vasoconstrictors in pulmonary artery and thoracic aorta and, impairs acetylcholine-induced pulmonary artery vasodilatation, by mechanisms involving at least partly NO signaling and oxidative stress.

Keywords: Chemerin; Nitric oxide; Pulmonary artery; Thoracic aorta; Vascular reactivity.

MeSH terms

  • Acetylcholine / pharmacology
  • Adipokines / metabolism
  • Animals
  • Chemokines / metabolism
  • Chemokines / physiology*
  • Endothelin-1 / metabolism
  • Endothelins / drug effects
  • Endothelium, Vascular / drug effects
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Intercellular Signaling Peptides and Proteins / physiology*
  • Male
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism
  • Nitroprusside / pharmacology
  • Oxidative Stress / drug effects
  • Phenylephrine / pharmacology
  • Pulmonary Artery / drug effects*
  • Pulmonary Artery / metabolism
  • Rats
  • Rats, Wistar
  • Serotonin / metabolism
  • Thoracic Arteries / drug effects
  • Thoracic Arteries / metabolism
  • Vasoconstriction / drug effects*
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects

Substances

  • Adipokines
  • Chemokines
  • Endothelin-1
  • Endothelins
  • Intercellular Signaling Peptides and Proteins
  • Rarres2 protein, rat
  • Vasoconstrictor Agents
  • Nitroprusside
  • Phenylephrine
  • Nitric Oxide
  • Serotonin
  • Acetylcholine
  • NG-Nitroarginine Methyl Ester